$4.36
-0.06-1.36%
At close: -
$4.50
0.143.17%
After Hours: Jan 30, 4:02 PM EDT
Senti Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Senti Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2024-03-21 | $-4.20 | $-2.30 | -82.6 % |
Q3 | 2023-11-13 | $-2.50 | $-4.40 | 43.2 % |
Q2 | 2023-08-11 | $-4.20 | $-4.80 | 12.5 % |
Q1 | 2023-05-09 | $-4.20 | $-4.30 | 2.33 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2024-03-21 | $0 | $300.00K | -100.0 % |
Q3 | 2023-11-13 | $338.00K | $700.00K | -51.7 % |
Q2 | 2023-08-11 | $937.00K | $500.00K | 87.4 % |
Q1 | 2023-05-09 | $1.29M | $470.00K | 173.6 % |
Senti Biosciences (SNTI) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-6.31, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.